Anne Lipke is a Respiratory physician affiliated with Swedish Medical Center. OpenAlex indexes 9 publications with 294 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
515 Minor Ave
Seattle, WA 981042120
Telephone
206-386-9500Provider last certified this registry record 18 May 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
- Insmed, Inc.Program year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
57%Corticosteroid31.6%Trelegy Ellipta44%Symbicort13%Fluticasone Propionate11%Breztri Aerosphere10%Breo Ellipta8%Budesonide-Formoterol Fumarate8%Dulera3%Breyna3%Part D<11 patientsbeta2-Adrenergic Agonist14.4%Albuterol Sulfate Hfa89%Ventolin Hfa11%Part D≥140 patients+ 5 more classes in this area
Metabolism & gastrointestinal
21.2%Corticosteroid9.1%Prednisone100%Part D≥123 patientsProton pump inhibitor8.8%Omeprazole77%Pantoprazole Sodium18%Lansoprazole5%Part D<11 patients+ 2 more classes in this area
Anti-infectives
13.2%Macrolide Antimicrobial10.1%Azithromycin100%Part D≥97 patientsPenicillins with extended spectrum1.3%Amoxicillin-Clavulanate Potass100%Part D≥29 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2010 per NIH RePORTER. The latest:
- Mechanisms of enhanced lung epithelial injury in febrile hyperthermia
University of Washington
FY2010$59,918F32HL096348 - Mechanisms of enhanced lung epithelial injury in febrile hyperthermia
University of Washington
FY2009$59,402F32HL096348
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Death receptors mediate the adverse effects of febrile-range hyperthermia on the outcome of lipopolysaccharide-induced lung injury
American Journal of Physiology-Lung Cellular and Molecular Physiology
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Rod Oskouian, MD
Swedish Medical Center
Ralph Aye, MD
Swedish Medical Center
Kelly Paulson, MD, PhD
Swedish Medical Center
Christopher McGann, MD
Swedish Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”